Clinical symptoms, diagnosis, and treatment of neurocysticercosis

The Lancet Neurology

Volumn 13, Issue 12, 2014, Pages 1202-1215

  Garcia, Hector H ^a,b   Nash, Theodore E ^c   Del Brutto, Oscar H ^d,e  

^a INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^b Universidad Peruana Cayetano Heredia   (Peru)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSIDAD ESPÍRITU SANTO   (Ecuador)

^e HOSPITAL CLÍNICA KENNEDY   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT;

BRAIN INFARCTION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; EPILEPSY; HUMAN; HYDROCEPHALUS; INTERMEDIATE HOST; INTRACRANIAL HYPERTENSION; LIFE CYCLE STAGE; NERVOUS SYSTEM INJURY; NEUROCYSTICERCOSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SEIZURE; SERODIAGNOSIS; TAENIA SOLIUM; ANIMAL; ISOLATION AND PURIFICATION; PIG; PROCEDURES; SEIZURES; TRANSMISSION; TREATMENT OUTCOME;

ANIMALS; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROCYSTICERCOSIS; SEIZURES; SWINE; TAENIA SOLIUM; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84919330439     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70094-8     Document Type: Review

References (142)

1. Singh G, Burneo JG, Sander JW From seizures to epilepsy and its substrates: neurocysticercosis. Epilepsia 2013, 54:783-792.
2. Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002, 8:608-613.
3. Croker C, Redelings M, Reporter R, Sorvillo F, Mascola L, Wilkins P The impact of neurocysticercosis in California: a review of hospitalized cases. PLoS Med 2012, 6:1-6.
4. Coyle CM, Mahanty S, Zunt JR, et al. Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 2012, 6:e1500.
5. Del Brutto OH, Garcia HH Neurocysticercosis. Handb Clin Neurol 2013, 114:313-325.
6. Ndimubanzi PC, Carabin H, Budke CM, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 2010, 4:e870.
7. DeGiorgio CM, Houston I, Oviedo S, Sorvillo F Deaths associated with cysticercosis. Report of three cases and review of the literature. Neurosurg Focus 2002, 12:e2.
8. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 2011, 9:123-133.
9. Bhattarai R, Budke CM, Carabin H, et al. Estimating the non-monetary burden of neurocysticercosis in Mexico. PLoS Negl Trop Dis 2012, 6:e1521.
10. First WHO report on neglected tropical diseases 2009, WHO, World Health Organization, Geneva.
11. Fabiani S, Bruschi F Neurocysticercosis in Europe: still a public health concern not only for imported cases. Acta Trop 2013, 128:18-26.
12. Serpa JA, White AC Neurocysticercosis in the United States. Pathog Glob Health 2012, 106:256-260.
13. Zammarchi L, Strohmeyer M, Bartalesi F, et al. Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. PloS One 2013, 8:e69537.
14. Alarcon TA, Del Brutto OH Neurocysticercosis: declining incidence among patients admitted to a large public hospital in Guayaquil, Ecuador. Pathog Glob Health 2012, 106:310-311.
15. Flisser A, Correa D Neurocysticercosis may no longer be a public health problem in Mexico. PLoS Negl Trop Dis 2010, 4:e831.
16. Garcia HH, Gonzalez AE, Evans CAW, Gilman RH Taenia solium cysticercosis. Lancet 2003, 362:547-556. Cysticercosis Working Group in Peru.
17. Flisser A Taeniasis and cysticercosis due to Taenia solium. Prog Clin Parasitol 1994, 4:77-116.
18. Sarti-Gutierrez EJ, Schantz PM, Lara-Aguilera R, Gomez Dandoy H, Flisser A Taenia solium taeniasis and cysticercosis in a Mexican village. Trop Med Parasitol 1988, 39:194. 148.
19. Lescano AG, Garcia HH, Gilman RH, et al. Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on uman seroprevalence but not on seizures. PLoS Negl Tropical Dis 2009, 3:e371.
20. O'Neal SE, Moyano LM, Ayvar V, et al. Geographic correlation between tapeworm carriers and heavily infected cysticercotic pigs. PLoS Negl Trop Dis 2012, 6:e1953.
21. Diaz F, Garcia HH, Gilman RH, et al. Epidemiology of taeniasis and cysticercosis in a Peruvian village. Am J Epidemiol 1992, 135:875-882. the cysticercosis working group in Peru.
22. Sarti E, Schantz PM, Plancarte A, et al. Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hygiene 1992, 46:677-685.
23. Yoshino K Studies on the post-embryonal development of Taenia solium: III. On the development of cysticercus cellulosae within the definitive intermediate host. J Med Assoc Formosa 1933, 32:166-169.
24. Yoshino K Studies on the post-embryonal development of Taenia solium: II. On the youngest form of cysticercus cellulosae and on the migratory course of the oncosphera of Taenia solium within the intermediate host. J Med Assoc Formosa 1933, 32:155-158.
25. Santamaria E, Plancarte A, de Aluja AS The experimental infection of pigs with different numbers of Taenia solium eggs: immune response and efficiency of establishment. J Parasitol 2002, 88:69-73.
26. de Aluja AS, Martinez MJ, Villalobos AN Taenia solium cysticercosis in young pigs: age at first infection and histological characteristics. Vet Parasitol 1998, 76:71-79.
27. Terrazas LI, Bojalil R, Rodriguez-Sosa M, Govezensky T, Larralde C Taenia crassiceps cysticercosis: a role for prostaglandin E2 in susceptibility. Parasitol Res 1999, 85:1025-1031.
28. Terrazas LI, Sanchez-Munoz F, Perez-Miranda M, et al. Helminth excreted/secreted antigens repress expression of LPS-induced Let-7i but not miR-146a and miR-155 in human dendritic cells. BioMed Res Int 2013, 2013:972506.
29. Terrazas LI The complex role of pro- and anti-inflammatory cytokines in cysticercosis: immunological lessons from experimental and natural hosts. Curr Top Medicinal Chem 2008, 8:383-392.
30. Hernandez JL, Leung G, McKay DM Cestode regulation of inflammation and inflammatory diseases. Int J Parasitol 2013, 43:233-243.
31. Gundra UM, Mishra BB, Wong K, Teale JM Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis. Infect Immun 2011, 79:2586-2596.
32. Verma A, Prasad KN, Nyati KK, et al. Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis. Parasitol 2011, 138:1423-1428.
33. Ramirez-Aquino R, Radovanovic I, Fortin A, et al. Identification of loci controlling restriction of parasite growth in experimental Taenia crassiceps cysticercosis. PLoS Negl Trop Dis 2011, 5:e1435.
34. Tato P, Fernandez AM, Solano S, et al. A cysteine protease from Taenia solium metacestodes induce apoptosis in human CD4+ T-cells. Parasitol Res 2004, 92:197-204.
35. Nash TE, Pretell EJ, Lescano AG, et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 2008, 7:1099-1105.
36. Garcia HH, Del Brutto OH Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005, 4:653-661.
37. Estanol B, Corona T, Abad P A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry 1986, 49:1131-1134.
38. Nash TE, Garcia HH Diagnosis and treatment of neurocysticercosis. Nat Rev 2011, 7:584-594.
39. Garcia HH, Gonzalez AE, Gilman RH Cysticercosis of the central nervous system: how should it be managed?. Curr Opin Infect Dis 2011, 24:423-427.
40. Carabin H, Ndimubanzi PC, Budke CM, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 2011, 5:e1152.
41. Del Brutto OH Neurocysticercosis in infants and toddlers: report of seven cases and review of published patients. Pediatr Neurol 2013, 48:432-435.
42. Garcia HH, Gonzalez AE, Rodriguez S, et al. Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurol 2010, 75:654-658.
43. Del Brutto VJ, Del Brutto OH, Ochoa E, Garcia HH Single parenchymal brain cysticercus: relationship between age of patients and evolutive stage of parasites. Neurol Res 2012, 34:967-970.
44. Nash TE, Patronas NJ Edema associated with calcified lesions in neurocysticercosis. Neurol 1999, 53:777-781.
45. Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg 2010, 104:243-250.
46. Rangel R, Torres B, Del Bruto O, Sotelo J Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg 1987, 36:387-392.
47. Rajshekhar V, Jeyaseelan L Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurol 2004, 62:2236-2240.
48. Thurman DJ, Beghi E, Begley CE, et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011, 52(suppl 7):2-26.
49. Medina MT, Aguilar-Estrada RL, Alvarez A, et al. Reduction in rate of epilepsy from neurocysticercosis by community interventions: the Salama, Honduras study. Epilepsia 2011, 52:1177-1185.
50. Montano SM, Villaran MV, Ylquimiche L, et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurol 2005, 65:229-233.
51. Del Brutto OH, Santibanez R, Idrovo L, et al. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 2005, 46:583-587.
52. de Souza A, Nalini A, Kovoor JM, Yeshraj G, Siddalingaiah HS, Thennarasu K Perilesional gliosis around solitary cerebral parenchymal cysticerci and long-term seizure outcome: a prospective study using serial magnetization transfer imaging. Epilepsia 2011, 52:1918-1927.
53. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004, 350:249-258.
54. Chawla S, Husain N, Kumar S, Pal L, Tripathi M, Gupta RK Correlative MR imaging and histopathology in porcine neurocysticercosis. J Magn Reson Imaging 2004, 20:208-215.
55. Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurol 2004, 62:1934-1938.
56. Nash TE, Pretell J, Garcia HH Calcified cysticerci provoke perilesional edema and seizures. Clin Infect Dis 2001, 33:1649-1653.
57. Storms AD, Greisman LR, Furst J, Andrews P, Lantos G, Coyle CM A retrospective review of calcified neurocysticercosis in a New York City hospital. Am Trop Med Hyg 2010, 83(suppl 5):1.
58. Fujita M, Mahanty S, Zoghbi SS, et al. PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema. PLoS One 2013, 8:e74052.
59. Otte WM, Singla M, Sander JW, Singh G Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. Neurol 2013, 80:152-162.
60. Sharma LN, Garg RK, Verma R, Singh MK, Malhotra HS Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebral calcification: a comparative evaluation. Seizure 2013, 22:840-845.
61. Mall RK, Agarwal A, Garg RK, Kar AM, Shukla R Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 2003, 44:1397-1401.
62. Kalra V, Dua T, Kumar V Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 2003, 143:111-114.
63. Garg RK, Potluri N, Kar AM, et al. Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect 2006, 53:65-69.
64. Rathore C, Thomas B, Kesavadas C, Abraham M, Radhakrishnan K Calcified neurocysticercosis lesions and antiepileptic drug-resistant epilepsy: a surgically remediable syndrome?. Epilepsia 2013, 54:1815-1822.
65. Rathore C, Thomas B, Kesavadas C, Radhakrishnan K Calcified neurocysticercosis lesions and hippocampal sclerosis: potential dual pathology?. Epilepsia 2012, 53:e60-e62.
66. Bianchin MM, Velasco TR, Santos AC, Sakamoto AC On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: coincidence or a pathogenic relationship?. Pathog Glob Health 2012, 106:280-285.
67. Cantu C, Barinagarrementeria F Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 1996, 53:233-239.
68. Callacondo D, Garcia HH, Gonzales I, Escalante D, Nash TE High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurol 2012, 78:1394-1400.
69. Lobato RD, Lamas E, Portillo JM, et al. Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations. J Neurosurg 1981, 55:786-793.
70. Torres-Corzo JG, Tapia-Perez JH, Vecchia RR, Chalita-Williams JC, Sanchez-Aguilar M, Sanchez-Rodriguez JJ Endoscopic management of hydrocephalus due to neurocysticercosis. Clin Neurol Neurosurg 2010, 112:11-16.
71. Santo AH Cysticercosis-related mortality in the state of Sao Paulo, Brazil, 1985-2004: a study using multiple causes of death. Cad Saude Publica 2007, 23:2917-2927.
72. Gilman RH, Del Brutto OH, Garcia HH, Martinez M Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. Neurol 2000, 55:1062. the Cysticercosis Working Group in Peru.
73. Garcia HH, Del Brutto OH Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. Neurol 1999, 53:1582-1584. the Cysticercosis Working Group in Peru.
74. Rodrigues CL, de Andrade DC, Livramento JA, et al. Spectrum of cognitive impairment in neurocysticercosis: differences according to disease phase. Neurol 2012, 78:861-866.
75. Wallin MT, Pretell EJ, Bustos JA, et al. Cognitive changes and quality of life in neurocysticercosis: a longitudinal study. PLoS Negl Trop Dis 2012, 6:e1493.
76. Bianchin MM, Dal Pizzol A, Scotta Cabral L, et al. Cognitive impairment and dementia in neurocysticercosis: a cross-sectional controlled study. Neurol 2010, 75:1028-1029.
77. Rajshekhar V Severe episodic headache as the sole presenting ictal event in patients with a solitary cysticercus granuloma. Acta neurologica Scandinavica 2000, 102:44-46.
78. Del Brutto OH, Del Brutto VJ Calcified neurocysticercosis among patients with primary headache. Cephalalgia 2012, 32:250-254.
79. Cantu C, Barinagarrementeria F Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 1996, 53:233-239.
80. Sa DS, Teive HA, Troiano AR, Werneck LC Parkinsonism associated with neurocysticercosis. Parkinsonism Relat Disord 2005, 11:69-72.
81. Lath R, Rajshekhar V Solitary cysticercus granuloma of the brainstem. Report of four cases. J Neurosurg 1998, 89:1047-1051.
82. Jayakumar PN, Chandrashekar HS, Ellika S Imaging of parasitic infections of the central nervous system. Handbook Clin Neurol 2013, 114:37-64.
83. Lerner A, Shiroishi MS, Zee CS, Law M, Go JL Imaging of neurocysticercosis. Neuroimag Clin N Am 2012, 22:659-676.
84. Dumas JL, Vusy JM, Belin C Parenchymal neurocysticercosis: follow up and staging by MRI. Neuroradiol 1997, 39:12-16.
85. Garcia HH, Del Brutto OH Imaging findings in neurocysticercosis. Acta Tropica 2003, 87:71-78.
86. Govindappa SS, Narayanan JP, Krishnamoorthy VM, Shastry CH, Balasubramaniam A, Krishna SS Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequences. AJNR Am J Neuroradiol 2000, 21:679-684.
87. Mont'Alverne Filho FE, Machado Ldos R, Lucato LT, Leite CC The role of 3D volumetric MR sequences in diagnosing intraventricular neurocysticercosis: preliminar results. Arq Neuropsiquiatr 2011, 69:74-78.
88. Neyaz Z, Patwari SS, Paliwal VK Role of FIESTA and SWAN sequences in diagnosis of intraventricular neurocysticercosis. Neurol India 2012, 60:646-647.
89. Verma A, Awasthi R, Prasad KN, et al. Improved detection of parenchymal cysticercal lesions in neurocysticercosis with T2*-weighted angiography magnetic resonance imaging. Acad Radiol 2012, 19:958-964.
90. Tsang VC, Brand JA, Boyer AE An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989, 159:50-59.
91. Rodriguez S, Dorny P, Tsang VC, et al. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis 2009, 199:1345-1352.
92. Rodriguez S, Wilkins P, Dorny P Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health 2012, 106:286-298.
93. Odashima NS, Takayanagui OM, Figueiredo JF Enzyme linked immunosorbent assay (ELISA) for the detection of IgG, IgM, IgE and IgA against cysticercus cellulosae in cerebrospinal fluid of patients with neurocysticercosis. Arq Neuropsiquiatr 2002, 60:400-405.
94. Michelet L, Fleury A, Sciutto E, et al. Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid. J Clin Microbiol 2011, 49:195-200.
95. Zamora H, Castillo Y, Garcia HH, et al. Drop in antigen levels following successful treatment of subarachnoid neurocysticercosis. Am J Trop Med Hyg 2005, 73:s41.
96. Fleury A, Garcia E, Hernandez M, et al. Neurocysticercosis: HP10 antigen detection is useful for the follow-up of the severe patients. PLoS Negl Trop Dis 2013, 7:e2096.
97. Correa D, Sandoval MA, Harrison LJ, et al. Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg 1989, 83:814-816.
98. Garcia HH, Harrison LJ, Parkhouse RM, et al. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. Trans R Soc Trop Med Hyg 1998, 92:411-414. the Cysticercosis Working Group in Peru.
99. Del Brutto OH, Sotelo J Neurocysticercosis: an update. Rev Infect Dis 1988, 10:1075-1087.
100. Allan JC, Avila G, Garcia Noval J, Flisser A, Craig PS Immunodiagnosis of taeniasis by coproantigen detection. Parasitol 1990, 101:473-477.
101. Bustos JA, Rodriguez S, Jimenez JA, et al. Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. Clin Vaccine Immunol 2012, 19:570-573.
102. Rajshekhar V, Chandy MJ Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurologica Scandinavica 1997, 96:76-81.
103. Del Brutto OH Diagnostic criteria for neurocysticercosis, revisited. Pathog Glob Health 2012, 106:299-304.
104. White A, Weller PF Cestode Infections. Harrison's principles of internal medicine 2012, McGraw-Hill, New York, NY. 18th edn. D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J. Jameson, J. Loscalzo (Eds.).
105. Prasad KN, Prasad A, Gupta RK, et al. Neurocysticercosis in patients with active epilepsy from the pig farming community of Lucknow district, north India. Trans R Soc Trop Med Hyg 2009, 103:144-150.
106. Millogo A, Nitiema P, Carabin H, et al. Prevalence of neurocysticercosis among people with epilepsy in rural areas of Burkina Faso. Epilepsia 2012, 53:2194-2202.
107. Rottbeck R, Nshimiyimana JF, Tugirimana P, et al. High prevalence of cysticercosis in people with epilepsy in southern Rwanda. PLoS Negl Trop Dis 2013, 7:e2558.
108. Machado Ldos R The diagnosis of neurocysticercosis: a closed question?. Arq Neuropsiquiatr 2010, 68:1-2.
109. Callaghan N, Garrett A, Goggin T Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study. N Engl J Med 1988, 318:942-946.
110. Arts WF, Visser LH, Loonen MC, et al. Follow-up of 146 children with epilepsy after withdrawal of antiepileptic therapy. Epilepsia 1988, 29:244-250.
111. Carpio A, Hauser WA Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurol 2002, 59:1730-1734.
112. Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010, 51:671-675.
113. Singh G, Rajshekhar V, Murthy JM, et al. A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurol 2010, 75:2236-2245.
114. Del Brutto OH Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurol 1994, 44:1706-1769.
115. Flisser A, Madrazo I, Plancarte A, et al. Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet 1993, 342:748.
116. Garcia HH, Gonzalez I, Mija L Neurocysticercosis uncovered by single-dose albendazole. N Engl J Med 2007, 356:1277-1278.
117. Nash TE, Mahanty S, Garcia HH Corticosteroid use in neurocysticercosis. Expert Rev Neurother 2011, 11:1175-1183.
118. Mejia R, Nash TE Corticosteroid withdrawal precipitates perilesional edema around calcified Taenia solium cysts. Am J Trop Med Hyg 2013, 89:919-923.
119. Garcia HH, Gonzales I, Lescano AG, et al. Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after. Epilepsia 2014, (in press).
120. Carpio A, Santillan F, Leon P, Flores C, Hauser WA Is the course of neurocysticercosis modified by treatment with antihelminthic agents?. Arch Intern Med 1995, 155:1982-1988.
121. Sotelo J, del Brutto OH, Penagos P, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 1990, 237:69-72.
122. Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2008, 79:1050-1055.
123. Das K, Mondal GP, Banerjee M, Mukherjee BB, Singh OP Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study. J Clin Neurosci 2007, 14:1172-1177.
124. Corona T, Lugo R, Medina R, Sotelo J Single-day praziquantel therapy for neurocysticercosis. N Engl J Med 1996, 334:125.
125. Pretell EJ, Garcia HH, Gilman RH, Saavedra H, Martinez M Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. Clin Neurol Neurosurg 2001, 103:175-177. the Cysticercosis Working Group in Peru.
126. Del Brutto OH, Roos KL, Coffey CS, Garcia HH Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006, 145:43-51.
127. Garcia HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002, 15:747-756.
128. Proano JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001, 345:879-885.
129. Bang OY, Heo JH, Choi SA, Kim DI Large cerebral infarction during praziquantel therapy in neurocysticercosis. Stroke 1997, 28:211-213.
130. Mitre E, Talaat KR, Sperling MR, Nash TE Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis. Clin Infect Dis 2007, 44:549-553.
131. Sotelo J, Marin C Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. J Neurosurg 1987, 66:686-689.
132. Suastegui Roman RA, Soto-Hernandez JL, Sotelo J Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J Neurosurg 1996, 84:629-633.
133. Rajshekhar V Surgical management of neurocysticercosis. Int J Surg 2010, 8:100-104.
134. Rangel-Castilla L, Serpa JA, Gopinath SP, Graviss EA, Diaz-Marchan P, White AC Contemporary neurosurgical approaches to neurocysticercosis. Am J Trop Med Hyg 2009, 80:373-378.
135. Proano JV, Torres-Corzo J, Rodriguez-della Vecchia R, Guizar-Sahagun G, Rangel-Castilla L Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv Syst 2009, 25:1467-1475.
136. Del Brutto OH, Garcia HH Intramedullary cysticercosis of the spinal cord: a review of patients evaluated with MRI. J Neurol Sci 2013, 331:114-117.
137. Yadav SK, Winter I, Singh SK Management of intra-vitreal cysticercosis. Nepal J Ophthalmol 2009, 1:143-145.
138. Schantz PM, Cruz M, Sarti E, Pawlowski Z Potential eradicability of taeniasis and cysticercosis. Bull Pan Am Health Organ 1993, 27:397-403.
139. Flisser A, Gauci CG, Zoli A, et al. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 2004, 72:5292-5297.
140. Gonzalez AE, Gauci CG, Barber D, et al. Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg 2005, 72:837-839.
141. Garcia HH, Gonzalez AE, Del Brutto OH, et al. Strategies for the elimination of taeniasis/cysticercosis. J Neurol Sci 2007, 262:153-157.
142. Assana E, Kyngdon CT, Gauci CG, et al. Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 2010, 40:515-519.